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Interspecies hybrids of Cryptococcus neoformans and 
C. gattii have only recently been reported. We describe a 
novel C. neoformans × C. gattii hybrid strain (serotype AB) 
that was previously described as C. gattii and that caused a 
lethal infection in an AIDS patient from Canada.
C
ryptococcus neoformans and C. gattii are pathogenic 
yeasts that may cause meningoencephalitis. C. neo-
formans primarily infects immunocompromised patients 
and occurs worldwide, whereas C. gattii primarily mainly 
infects otherwise healthy persons and has been thought to 
occur in subtropical regions (1–3). However, the recent 
outbreak of infection with C. gattii on Vancouver Island, 
British Columbia, Canada (4), expansion of this outbreak 
to mainland Canada and the Paciﬁ  c Northwest region of the 
United States (5), and identiﬁ  cation of C. gattii isolates in 
Europe (6) show that C. gattii can also occur in temperate 
climates. Molecular techniques can distinguish 7 haploid 
genotypic groups within C. neoformans and C. gattii (7–9; 
F. Hagen and T. Boekhout, unpub. data).
Recently, 3 serotype BD C. neoformans var. neofor-
mans × C. gattii hybrids were isolated from 2 HIV-negative 
patients in the Netherlands (10). We describe a novel C. 
neoformans var. grubii serotype A × C. gattii serotype B 
hybrid that was isolated from an HIV-positive person.
The Study
Strain CBS10496 was isolated from a 31-year-old 
AIDS patient from Montreal, Quebec, Canada, who had 
traveled to Mexico ≈15 months before cryptococcosis was 
diagnosed. The patient died despite extensive antifungal 
treatment with ketoconazole and amphotericin B (11). 
CBS10496 has been identiﬁ  ed as C. gattii serotype B (cited 
as C. neoformans var. gattii) (11). Reference isolates used 
in this study are listed in the Table.
The ploidy of CBS10496 was determined by using 
ﬂ  ow cytometry (10) with the sequenced haploid strains 
CBS8710 and CBS10510 as references. Nuclei were vi-
sualized after staining with 4′,6-diamidino-2-phenylindole 
(10). Coloration of colonies grown on canavanine-glycine-
bromthymol blue (CGB) medium (12) was determined 
after incubation at 24°C for 6 and 15 days. The serotype 
of CBS10496 was determined by using the CryptoCheck 
serotyping kit (Iatron Laboratories, Tokyo, Japan).
Ten colonies of CBS10496 were used for DNA ex-
traction (10). DNA of these colonies was used for ampli-
ﬁ  ed fragment length polymorphism (AFLP) analysis (7). 
The partial sequence of 6 nuclear regions was determined 
for reference isolates CBS10488–CBS10490, CBS1622, 
CBS6992, and the putative hybrid isolate CBS10496. Se-
lected nuclear regions were those for internal transcribed 
spacer (ITS) region, intergenic spacer region, laccase (CN-
LAC1), 2 RNA polymerase II subunits (RPB1 and RPB2), 
and translation elongation factor 1α (TEF1α) (9,10). Mating 
types and serotype were determined as described (10,13).
DNA content of CBS10496 was compared with 
that of CBS8710 and CBS10510. The G1 peak of refer-
ence strains was located at positions 31.6 (CBS8710) and 
31.1 (CBS10510), and the G2 peak was located at posi-
tions 65.8 (CBS8710) and 56.4 (CBS10510). The G1 
peak of CBS10496 was located at position 57.5, and the 
G2 peak was located at position 115.7. Thus, the G1 peak 
of CBS10496 coincided with the G2 peak of the haploid 
strains (Figure 1, panel A), which indicates that CBS10496 
has ≈2× more DNA than haploid strains. We concluded 
that CBS10496 is diploid or aneuploid. Staining with 4′,6-
diamidino-2-phenylindole showed that cells of CBS10496 
were monokaryotic (Figure 1, panel B).
Reaction of CBS10496 on CGB medium was nega-
tive, which corresponds to C. neoformans (12). The Cryp-
toCheck serotyping kit serum factors 5 (corresponding to 
serotype B) and 7 (corresponding to serotype A) aggluti-
nated, which indicated that CBS10496 is a serotype AB 
strain.
The AFLP ﬁ  ngerprint obtained by analysis of colo-
nies of CBS10496 did not match any of the previously 
deﬁ  ned AFLP genotypes. The ﬁ  ngerprint of CBS10496 
was compared with AFLP ﬁ  ngerprints of reference strains 
CBS8710 and CBS9172, which are AFLP1/VNI, and E566 
and CBS10510, which are AFLP4/VGI. The AFLP ﬁ  nger-
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 7, July 2008  1105 
*Centraalbureau voor Schimmelcultures–Fungal Biodiversity Cen-
tre, Utrecht, the Netherlands; †University Medical Centre Utrecht, 
Utrecht; ‡Netherlands Institute of Ecology, Nieuwersluis, the Neth-
erlands; §Institut Pasteur, Paris, France; and ¶Laboratoire Santé 
Publique Quebec, Sainte-Anne-de-Bellevue, Quebec, Canada
DOI: 10.3201/eid1407.080122
1These authors contributed equally to this article.
2Current afﬁ  liation: Netherlands Commission on Genetic Modiﬁ  cation, 
Bilthoven, the Netherlands. print of CBS10496 contained fragments characteristic of 
AFLP1/VNI and AFLP4/VGI (Figure 2), which indicated 
that genetic material from these 2 genotypes was present in 
this isolate.
Two alleles representing AFLP1/VNI and AFLP4/VGI 
were found when fragments of RPB1,  RPB2,  CNLAC1, 
and intergenic spacer region of CBS10496 were cloned 
and sequenced. However, after 30 clones were sequenced, 
only 1 allele was obtained for TEF1α, i.e., AFLP4/VGI, 
and ITS, i.e., AFLP1/VNI. Our results indicate that genetic 
material from AFLP1/VNI and AFLP4/VGI was pres-
ent in CBS10496, although only 1 allele was obtained for 
TEF1α and ITS. All sequences were submitted to GenBank 
(accession nos. DQ286656–DQ286676 and EF102027–
EF102072).
Ampliﬁ  cation of CBS10496 in a PCR with the MATα 
and the MATα serotype A–speciﬁ  c primer pair resulted in an 
amplicon. When MATa and the MATa serotype A–speciﬁ  c 
PCRs were conducted, no amplicon was obtained. These 
ﬁ  ndings indicate that CBS10496 has a MATα serotype A 
background. All reference strains yielded amplicons with 
the expected primer pairs. In addition, CBS10510, a MATα 
serotype B strain, was ampliﬁ  ed with the MATα speciﬁ  c 
primer pair, and E566, a MATa serotype B strain, yielded 
an amplicon with the MATa-speciﬁ  c PCR. These results in-
dicate that a C. gattii and a MATα serotype A background 
are present in CBS10496. Because the mating type of the 
C. gattii background within CBS10496 was unknown, 30 
MATα clones of CBS10496 were sequenced to determine 
whether a MATα serotype B allele could be identiﬁ  ed. 
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Table. Cryptococcus spp. strains used in this study* 
Strain† 
Mating 
type‡/serotype 
AFLP/M13 
genotype§  Source Country 
CBS9172  aA  AFLP1/VNI  Soil sample from garden of patient with 
neighboring bird colonies 
Italy 
CBS8710 (H99)  ĮA  AFLP1/VNI  Patient with Hodgkin disease  United States 
CBS1622  ĮB AFLP4/VGI  Tumor  France 
CBS6992  ĮB AFLP4/VGI  Human  Unknown 
E566 aB  AFLP4/VGI  Eucalyptus camaldulensis  Australia 
CBS10510 (WM276)  ĮB AFLP4/VGI  Debris  of  E. tereticornis Australia 
CBS10488 (AMC770616)  ĮBaD  AFLP8/NA  Human CSF  The Netherlands 
CBS10489 (AMC2010404)  ĮBaD  AFLP8/NA  Human CSF  The Netherlands 
CBS10490 (AMC2011225)  ĮBaD  AFLP8/NA  Human CSF  The Netherlands 
CBS10496 (LSPQ#308)  ĮA–B  AFLP9/NA  Blood of an HIV-positive patient  Canada 
*AFLP, amplified fragment length polymorphism; CBS, Fungal Biodiversity Centre; AMC, Netherlands Reference Laboratory for Bacterial Meningitis, 
Academic Medical Center, Amsterdam, the Netherlands; NA, not applicable; CSF, cerebrospinal fluid. 
†Origin and genetic composition of the strains are indicated.  
‡ –, mating type unknown.  
§AFLP fingerprint genotype (7), followed by corresponding M13 PCR fingerprint genotype (8). 
Figure 1. A) Determination of ploidy of the novel Cryptococcus neoformans × C. gattii serotype AB hybrid isolate CBS10496 by ﬂ  ow 
cytometry. The ﬁ  rst peak corresponds to the G1 phase; the second peak corresponds to the G2 phase. Haploid reference strain CBS10510 
is shown by the red line; CBS10496 is shown by the black line. The G1 peak of CBS10496 coincided with the G2 peak of strain CBS10510, 
which indicated that strain CBS10496 has approximately twice the amount of DNA than CBS10510. B) Nuclear staining of isolate CBS10496 
with 4′,6-diamidino-2-phenylindole, showing that cells are monokaryotic. Scale bar = 10 μm.Lethal C. neoformans × C. gattii Hybrid
However, all clones were MATα serotype A; no MATα se-
rotype B clones were found.
Conclusions
Our results indicated that CBS10496 is a monokary-
otic, diploid, or aneuploid strain with the novel AB sero-
type. AFLP and sequence analysis showed that the isolate 
contained fragments of C. neoformans var. grubii (AFLP1/
VNI) and C. gattii (AFLP4/VGI). We conclude that this 
isolate is a novel aneuploid hybrid of C. neoformans var. 
grubii (serotype A, AFLP1/VNI) and C. gattii (serotype B, 
AFLP4/VGI).
CBS10496 had been identiﬁ  ed as C. gattii on the ba-
sis of a weak positive reaction on CGB medium (11). Our 
results indicated that CBS10496 was negative on CGB me-
dium. Although a negative response on CGB medium has 
been shown for other C. neoformans × C. gattii hybrids 
(10,14), weak and delayed positive reactions on CGB me-
dium may occur in C. neoformans × C. gattii hybrid isolates 
(10,14). CBS10496 was previously identiﬁ  ed as a serotype 
B strain (11). Inconsistent serotyping results have been re-
ported for other hybrids (10,15) and may result from differ-
ences in speciﬁ  city and potency among different batches of 
factor serum. All C. neoformans × C. gattii hybrids discov-
ered have originated from clinical sources (13; F. Hagen 
and T. Boekhout, unpub. data).
We expected that CBS10496 would have 2 mating-
type loci. However, only a serotype A MATα background 
was observed. Although an amplicon was obtained with 
C. gattii–speciﬁ  c mating-type primers, the C. gattii back-
ground could not be linked to a mating type. We hypoth-
esize that the serotype AB C. neoformans × C. gattii hybrid 
CBS10496 was formed by mating of a MATa serotype B 
strain with a MATα serotype A strain and subsequent loss 
of the MATa serotype B allele. Detection of single ITS and 
TEF1α alleles in CBS10496 further supports our ﬁ  ndings 
because it indicates that other alleles were also lost. Loss of 
genetic material has been observed in other hybrids, such 
as serotype AD and BD hybrids (14), and seems to be a 
normal process in cryptococcal hybrids.
Our results show that the C. gattii parent of the sero-
type AB hybrid belongs to the AFLP4/VGI genotype, as 
was the case for serotype BD hybrids (10). The C. gattii 
parental sequence of all known serotype BD C. neoformans 
× C. gattii hybrid isolates was identical to sequences of 
AFLP4/VGI strains CBS1622 and CBS6992 in all regions 
studied (9). Detection of 1 speciﬁ  c C. gattii–AFLP4/VGI 
subgroup in all isolated C. neoformans × C. gattii hybrids 
may indicate that this subgroup preferentially forms inter-
species hybrids.
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